Manufacturer record

Medistark Biotech Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Medistark Biotech Pvt. Ltd were declared Not of Standard Quality between January 2025 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: MP-240840, Pantoprazole Sodium Gastro Resistant Tablets IP 40mg (Panzo 40) (exp Sep 2026). State Lab Puducherry (state lab) found it not of standard quality: For the received sample, label is mentioned as ?Approved colour used?. Listed in the June 2025 alert.

Records by type

2 records linked to Medistark Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2025 to Jun 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Misbranded
Most common failure
Jun 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pantoprazole Sodium Gastro Resistant Tablets IP 40mg (Panzo 40) Batch MP-240840Mfg Oct 2024 · Exp Sep 2026 For the received sample, label is mentioned as ?Approved colour used?Labelling State Lab PuducherryState lab Jun 2025
Metoprolol Succinate Extended Release & Telmisartan Tablets (Leaftel Beta ? 25) Batch MP - 231584Mfg Mar 2024 · Exp Feb 2026 The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. - MisbrandedMisbranded State Lab PuducherryState lab Jan 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.